Filter Results :

Your search for Therapies returned 73 reports

Sort by


Obesity Drugs and Therapies: Technologies and Global Markets

18 May 2016  |  Published by:  BCC Research
The global market for obesity treatments should reach over $7.8 billion by 2021 from over $4.3 billion in 2016 at a compound annual growth rate (CAGR) of 12.7% from 2016 to 2021. This report provides: -An overview of the global markets for obesity drugs, therapies, and related technologi...

$ 6,650.00

Read More

Global Cancer Immunotherapies Market 2016-2020

27 Apr 2016  |  Published by:  Technavio
About Cancer Immunotherapies Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of ...

$ 2,500.00

Read More

Intra-Cellular Therapies, Inc. (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

14 Mar 2016  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. It carries out the development of drugs for the treatment of diseases and disorders of the central nervous system (CNS). The company’s pipeline portfolio encompasses indications for the treatment of schizophrenia, bipolar di...

$ 250.00

Read More

Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies

01 Mar 2016  |  Published by:  GBI Research
SummaryAlzheimer’s Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages. The pathologica...

$ 4,995.00

Read More

Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

11 Feb 2016  |  Published by:  GBI Research
SummaryParkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia nigra region of the brain. The global Parkinson's Disease (PD) prevalence was...

$ 4,995.00

Read More

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

09 Jan 2016  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. It develops vitrogro, which is a ...

$ 300.00

Read More

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

01 Jan 2016  |  Published by:  GBI Research
SummaryDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated with long-term damage, dysfunction and fa...

$ 4,995.00

Read More

Targeted Therapies In Asthma: KOL Insight

01 Jan 2016  |  Published by:  FirstWord
Competition heating up as developers struggle to differentiate pipeline asthma antibodies Innovative monoclonal antibodies are breathing new life into the treatment of severe asthma. But with many of them targeting similar populations and providing similar benefits, finding a competitive ed...

$ 7,900.00

Read More

Biotie Therapies Corp. - Product Pipeline Review - 2015

30 Dec 2015  |  Published by:  Global Markets Direct
Summary‘Biotie Therapies Corp. - Product Pipeline Review - 2015’, provides an overview of the Biotie Therapies Corp.’s pharmaceutical research and d...

$ 1,500.00

Read More

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Industry 2015 Market Research Report

18 Dec 2015  |  Published by:  9Dimen Research
2015 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Autologous Stem Cell and Non-Stem Cell Based Therapies industry, focusing on the main regions (North America, Europ...

$ 2,850.00

Read More

Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report

20 Nov 2015  |  Published by:  QYResearch
The Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biomarker Technology Platforms for Cancer Diagnoses and Therapies industry.The report provides a basic overview of the in...

$ 2,800.00

Read More

Global Epigenetic R&D, Therapies and Diagnostics Industry 2015 Market Research Report

19 Nov 2015  |  Published by:  QYResearch
The Global Epigenetic R&D, Therapies and Diagnostics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Epigenetic R&D, Therapies and Diagnostics industry.The report provides a basic overview of the industry including definitions, classifications, a...

$ 2,800.00

Read More

Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

08 Nov 2015  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and...

$ 300.00

Read More

Vital Therapies, Inc. (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Sep 2015  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a biotherapeutic company that develops cell-based therapy targeting treatment for liver failure. The company’s clinical trials include VTI-206, VTI-201, VTIC-301, VTI-208, VTI-210 and VTI-212. Its product ELAD is a human-cell-based liver support syst...

$ 250.00

Read More

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

11 Sep 2015  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. TTL...

$ 250.00

Read More
Total 73 records.